Completed PHASE3 INTERVENTIONAL 2-arm NCT00561132

Study of Vanadium Supplement in Patients With Impaired Glucose Tolerance

Effect of Vanadium on Insulin Sensitivity in Patients With Impaired Glucose Tolerance

Sponsor: Doctorado en Farmacologia de la Universidad de Guadalajara

Interventions Magnesium oxide Vanadyl sulfate

Updated 4 times since 2017 Last updated: Nov 19, 2007 Started: Nov 30, 2003 Completion: Nov 30, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Prediabetic State and is currently completed. Doctorado en Farmacologia de la Universidad de Guadalajara leads this study, which shows 4 recorded versions since 2003 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2017 — Jan 2021 [monthly]

Completed PHASE3

First recorded

Nov 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Doctorado en Farmacologia de la Universidad de Guadalajara
Fondo para el Fomento a la Investigacion Medica
Unidad de Investigacion Medica en Epidemiologia Clinica

Data source: Unidad de Investigacion Medica en Epidemiologia Clinica

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guadalajara, Mexico